S03539 Summary:

BILL NOS03539A
 
SAME ASSAME AS A01181-A
 
SPONSORRIVERA
 
COSPNSRFELDER, JORDAN, RANZENHOFER
 
MLTSPNSR
 
Amd §6816-a, Ed L
 
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Go to top    

S03539 Actions:

BILL NOS03539A
 
02/08/2019REFERRED TO HIGHER EDUCATION
05/14/20191ST REPORT CAL.693
05/15/20192ND REPORT CAL.
05/20/2019AMENDED 3539A
05/20/2019ADVANCED TO THIRD READING
05/30/2019PASSED SENATE
05/30/2019DELIVERED TO ASSEMBLY
05/30/2019referred to higher education
01/08/2020died in assembly
01/08/2020returned to senate
01/08/2020REFERRED TO HIGHER EDUCATION
Go to top

S03539 Committee Votes:

Go to top

S03539 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S03539 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         3539--A
            Cal. No. 693
 
                               2019-2020 Regular Sessions
 
                    IN SENATE
 
                                    February 8, 2019
                                       ___________
 
        Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
          printed to be committed  to  the  Committee  on  Higher  Education  --
          reported  favorably  from  said committee, ordered to first and second
          report, amended on second report, ordered to a third reading,  and  to
          be  reprinted  as  amended,  retaining its place in the order of third
          reading
 
        AN ACT to amend the education law, in relation to  the  substitution  of
          brand name epinephrine auto-injectors with alternate epinephrine auto-
          injectors for dispensation by pharmacists
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Section 6816-a of the education law is amended by adding  a
     2  new subdivision 6 to read as follows:
     3    6.  (a)  Notwithstanding  subdivision two of this section or any other
     4  section of law to the contrary, when a patient  is  prescribed  a  brand
     5  name epinephrine auto-injector, a pharmacist may substitute an alternate
     6  epinephrine auto-injector containing the same active ingredients, dosage
     7  form  and  strength  as  the  brand  name product prescribed, ordered or
     8  demanded, regardless of whether the alternate epinephrine  auto-injector
     9  is  included in the latest list of interchangeable drug products for the
    10  prescribed epinephrine auto-injector device, provided that:
    11    (i) the prescriber does not indicate that  the  prescription  therefor
    12  shall  be  dispensed as written pursuant to paragraph (a) of subdivision
    13  six of section sixty-eight hundred ten of this article;
    14    (ii) the alternate epinephrine auto-injector available would reflect a
    15  lower unit cost to the purchaser;
    16    (iii) the pharmacist has advised the purchaser of the availability  of
    17  an  alternate epinephrine auto-injector and obtained consent to dispense
    18  the alternate epinephrine auto-injector; and
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD05192-04-9

        S. 3539--A                          2
 
     1    (iv) the pharmacist has counseled the patient or person authorized  to
     2  act  on  the patient's behalf on the proper usage and operating features
     3  of the alternate epinephrine auto-injector.
     4    (b) For purposes of this subdivision "epinephrine auto-injector" shall
     5  have the same meaning as provided in paragraph (b) of subdivision one of
     6  section three thousand-c of the public health law.
     7    § 2. This act shall take effect immediately.
Go to top